Published in Lab Business Week, October 1st, 2006
The international syndicate of investors was led by new investor KBC (Belgium), Belgium's leading bank for private and public equities. SR One (USA and U.K.), the venture capital arm of GSK, one of the world's leading research-based pharmaceutical and healthcare companies was the second new investor. All existing financial investors participated in the round - Abingworth Management (U.K.), Alta Partners (USA), Biotech Fund Flanders (Belgium), Gilde Healthcare Partners (The Netherlands), GIMV (Belgium) and Sofinnova Partners (France). In addition, VIB (Belgium) also participated to a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.